Article
PRISMA-combined Myeloperoxidase -463G/A gene polymorphism and coronary artery disease: A meta-analysis of 4744 subjects.
Medicine - 1 Mar 2017
Li Yan-Yan, Wang Hui, Qian Jin, Kim Hyun Jun, Wu Jing-Jing, Wang Lian-Sheng, Zhou Chuan-Wei, Yang Zhi-Jian, Lu Xin-Zheng
Abstract excerpt
BACKGROUND: Myeloperoxidase (MPO) -463G/A gene polymorphism may be associated with an increased risk of developing coronary artery disease (CAD). Studies on the subject, however, do not provide a clear consensus. This meta-analysis was performed to explore the relationship between MPO gene -463G/A polymorphism and CAD risk. METHODS: This meta-analysis combines data from 4744 subjects from 9 independent studies....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
